Evidence map›Paper›PMID 39025859›Full record

ArticleNature communications2024

Regioselective hydroamination of unactivated olefins with diazirines as a diversifiable nitrogen source.

Qingyu Xing, Preeti P Chandrachud, Khalilia Tillett, Justin M Lopchuk

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. The Versatility of Diazirines: Properties, Synthetic and Modern Applications.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qingyu XingDepartment of Chemistry, University of South Florida, Tampa, FL, 33620, USA.
Preeti P ChandrachudDrug Discovery Department, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL, 33612, USA.
Khalilia TillettDepartment of Chemistry, University of South Florida, Tampa, FL, 33620, USA.
Justin M LopchukDepartment of Chemistry, University of South Florida, Tampa, FL, 33620, USA. Justin.Lopchuk@Moffitt.org.ORCID http://orcid.org/0000-0002-6910-6132

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI Christine O'Connell · 1998 to 2026
$93.5M
New reagents for C-C and C-N bond formationR35GM142577 · NIGMS · H. LEE MOFFITT CANCER CTR & RES INST · PI LOPCHUK, JUSTIN MATTHEW · 2021 to 2025
$2.2M
National Science Foundation (NSF) CHE-2301063NCI NIH HHS P30 CA076292NIGMS NIH HHS R35 GM142577U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) P30-CA076292U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35-GM142577
6 · The paper itself

Abstract

Nitrogen-containing compounds, such as amines, hydrazines, and heterocycles, play an indispensable role in medicine, agriculture, and materials. Alkylated derivatives of these compounds, especially in sterically congested environments, remain a challenge to prepare. Here we report a versatile method for the regioselective hydroamination of readily available unactivated olefins with diazirines. Over fifty examples are reported, including the protecting group-free amination of fourteen different natural products. A broad functional group tolerance includes alcohols, ketones, aldehydes, and epoxides. The proximate products of these reactions are diaziridines, which, under mild conditions, are converted to primary amines, hydrazines, and heterocycles. Five target- and diversity-oriented syntheses of pharmaceutical compounds are shown, along with the preparation of a bis-

Identifiers

PMID39025859
PMCPMC11258257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.